Madrigal Pharmaceuticals (MDGL) Cash & Equivalents Growth (5y) (2015 - 2026)
Madrigal Pharmaceuticals (MDGL) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 15.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.72% |
| Dec 31, 2025 | 29.76% |
| Sep 30, 2025 | 22.06% |
| Jun 30, 2025 | 24.65% |
| Mar 31, 2025 | 22.47% |
| Dec 31, 2024 | 16.46% |
| Sep 30, 2024 | 21.06% |
| Jun 30, 2024 | 46.82% |
| Mar 31, 2024 | 67.30% |
| Dec 31, 2023 | 11.73% |
| Sep 30, 2023 | 10.28% |
| Jun 30, 2023 | -21.85% |
| Mar 31, 2023 | 24.34% |
| Dec 31, 2022 | 17.41% |
| Sep 30, 2022 | 35.57% |
| Jun 30, 2022 | 8.89% |
| Mar 31, 2022 | 38.77% |
| Dec 31, 2021 | 13.63% |
| Sep 30, 2021 | 42.42% |
| Jun 30, 2021 | 52.28% |